Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2006-7-21
pubmed:abstractText
Proliferation of vascular smooth muscle cells (VSMCs) contributes to restenosis after coronary intervention. We have shown previously that increased expression of plasminogen activator inhibitor type 1 (PAI-1) limits VSMC apoptosis. Because apoptosis and proliferation appear to be linked, we sought to determine whether increased PAI-1 would affect VSMC proliferation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1524-4636
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1777-83
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16709941-Adenoviridae, pubmed-meshheading:16709941-Animals, pubmed-meshheading:16709941-Aorta, pubmed-meshheading:16709941-Caspase 8, pubmed-meshheading:16709941-Caspases, pubmed-meshheading:16709941-Cell Division, pubmed-meshheading:16709941-Cell Proliferation, pubmed-meshheading:16709941-Cell Survival, pubmed-meshheading:16709941-Cells, Cultured, pubmed-meshheading:16709941-Enzyme Activation, pubmed-meshheading:16709941-Extracellular Signal-Regulated MAP Kinases, pubmed-meshheading:16709941-Mice, pubmed-meshheading:16709941-Mice, Transgenic, pubmed-meshheading:16709941-Muscle, Smooth, Vascular, pubmed-meshheading:16709941-Myocytes, Smooth Muscle, pubmed-meshheading:16709941-NF-kappa B, pubmed-meshheading:16709941-Plasminogen Activator Inhibitor 1, pubmed-meshheading:16709941-Transfection
pubmed:year
2006
pubmed:articleTitle
Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.
pubmed:affiliation
Department of Medicine and Cardiovascular Research Institute, University of Vermont, Burlington, USA. ybchen@path.uab.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't